Adrenocortical cell mitochondrial and steroidogenic machinery

The adrenocortical cell mitochondrial and steroidogenic machinery is a specialized functional unit within the adrenal cortex responsible for the biosynthesis of steroid hormones from cholesterol. This machinery involves the coordinated action of the mitochondria and various cytochrome P450 enzymes, including CYP11A1 (cholesterol side-chain cleavage enzyme) and CYP11B1 (11β-hydroxylase), which catalyze the rate-limiting and final steps of steroidogenesis (Source: StatPearls). This system is the primary therapeutic target for mitotane, an adrenolytic drug used to treat adrenocortical carcinoma and refractory Cushing's syndrome (Source: National Cancer Institute). Mitotane undergoes metabolic activation within the mitochondria to form reactive intermediates that bind to mitochondrial proteins, leading to the inhibition of steroidogenic enzymes and the induction of mitochondrial respiratory chain dysfunction (Source: PubMed). The resulting mitochondrial stress and damage trigger apoptosis and necrosis specifically in adrenocortical cells, effectively reducing tumor mass and hormone hypersecretion (Source: Orphanet). However, the destruction of this machinery often results in primary adrenal insufficiency, requiring lifelong glucocorticoid and mineralocorticoid replacement therapy (Source: Mayo Clinic).

Other names

Adrenal steroidogenesis pathwayMitochondrial steroidogenic enzymesAdrenocortical mitochondrial complexSteroidogenic machinery

Inhibition of mitochondrial respiration and induction of mitochondrial stress; inhibition of cytochrome P450 steroidogenic enzymes (CYP11A1, CYP11B1, CYP17A1); metabolic activation to reactive acyl chlorides that bind to mitochondrial proteins (Source: PubMed, StatPearls).